Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $35 ...

The potential health benefits of GLP-1 diabetes and weight loss meds keep piling up: New research shows they may also shield ...

About 42% of U.S. adults are obese, the CDC says. GLP-1 medications have changed the picture for people hoping to reduce ...

The Biden administration proposed a rule for Medicare and Medicaid to cover the costs of weight-loss drugs for millions of ...

Medicare and Medicaid would be required to cover weight loss drug prescriptions for millions of obese Americans under plans ...

The pharmaceutical manufacturer Amgen announced on Tuesday that an experimental obesity drug helped patients lose up to 20 ...

Millions of obese Americans would be eligible to have popular weight-loss drugs like Wegovy or Ozempic covered by Medicare or ...

This may be the first Thanksgiving for millions of Americans who are on GLP-1 agonists like Ozempic, Zepbound or Wegovy.

The Biden administration proposed expanding coverage of weight loss medication to Medicaid and Medicare recipients. RFK Jr.

The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.

Amgen's experimental drug MariTide helped overweight or obese patients shed up to 20% of their body weight in a mid-stage ...